NEW YORK (GenomeWeb) – Thermo Fisher Scientific has launched a program by which it will collaborate with partners to develop its next-generation sequencing-based Oncomine portfolio of products into clinical tests that can be used as companion diagnostics. The Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland will be the first partner in the initiative, dubbed the Next Generation Companion Dx Center of Excellence Program.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.